Business & Finance Lilly raised sales guidance for third time this year as Zepbound sales soar. Its stock is rallying.
The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.
By
· October 29, 2026 · 1 min read
This article was originally published by
MarketWatch
and is republished here under license.
The drugmaker continues to dominate the market for prescription weight-loss drugs in the U.S.
Related
Unlike other major central banks, the Swiss National Bank has a significant equity portfolio.…
By
· October 30, 2026 · 1 min read
The ride-hailing company Uber Technologies Inc. used a public blockchain to invest its corporate funds in a way that allowed…
By
· October 30, 2026 · 1 min read
Blackstone Inc.’s QTS and some of the biggest data center developers pledged to provide disclosures on their projects’ power demands,…
By
· October 30, 2026 · 1 min read
Leave a Reply